<P>The prevalence of allergic disorders has dramatically increased over the past decade, particularly in developed countries. Apart from gastrointestinal disorders, neoplasia, genital and dermatological diseases <I>etc</I>., dysregul...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107713608
2018
-
SCIE,SCOPUS,KCI등재
학술저널
575-590(16쪽)
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
<P>The prevalence of allergic disorders has dramatically increased over the past decade, particularly in developed countries. Apart from gastrointestinal disorders, neoplasia, genital and dermatological diseases <I>etc</I>., dysregul...
<P>The prevalence of allergic disorders has dramatically increased over the past decade, particularly in developed countries. Apart from gastrointestinal disorders, neoplasia, genital and dermatological diseases <I>etc</I>., dysregulation of gut microbiota (dysbiosis) has also been found to be associated with increased risk of allergies. Probiotics are increasingly being employed to correct dysbiosis and, in turn, to modulate allergic diseases. However, several factors like strain variations and effector metabolites or component of them in a bacterial species can affect the efficacy of those as probiotics. On the other hand, host variations like geographical locations, food habits <I>etc</I>. could also affect the expected results from probiotic usage. Thus, there is a glaring deficiency in our approach to establish probiotics as an irrefutable treatment avenue for suitable disorders. In this review, we explicate on the reported probiotics and their effects on certain allergic diseases like atopic dermatitis, food allergy and asthma to establish their utility. We propose possible measures like elucidation of effector molecules and functional mechanisms of probiotics towards establishing probiotics for therapeutic use. Certain probiotics studies have led to very alarming outcomes which could have been precluded, had effective guidelines been in place. Thus, we also propose ways to secure the safety of probiotics. Overall, our efforts tend to propose necessary discovery and quality assurance guidelines for developing probiotics as potential immunomodulatory ‘Pharmabiotics.’</P>
KAAACI Evidence-Based Clinical Practice Guidelines for Chronic Cough in Adults and Children in Korea
Asthma on the Run
Teachers TV Teachers TVAsthma on the Run: Mucus
Teachers TV Teachers TVAsthma on the Run: Mucus Production
Teachers TV Teachers TVAsthma on the Run: The Effect of Asthma on the Airways
Teachers TV Teachers TVAsthma on the Run: Lung Structure and Gas Exchange
Teachers TV Teachers TV